Legend Biotech Change in Accounts Receivable 2019-2025 | LEGN
Legend Biotech change in accounts receivable for the twelve months ending March 31, 2025 was $0.202B, a 310650.77% increase year-over-year.
- Legend Biotech annual change in accounts receivable for 2024 was $0.094B, a 194.72% decline from 2023.
- Legend Biotech annual change in accounts receivable for 2023 was $-0.099B, a 296.7% decline from 2022.
- Legend Biotech annual change in accounts receivable for 2022 was $0.05B, a 104.64% increase from 2021.